UroGen Pharma Ltd. (URGN)
NASDAQ·Healthcare·Biotechnology
$40.19
+4.15%
Mkt Cap $1.97B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (15 analysts)
$44.20
Range $40.00 – $50.00
Implied Upside
+10.0%
Consensus $44.20 vs current $40.19
NASDAQ·Healthcare·Biotechnology
$40.19
+4.15%
Mkt Cap $1.97B
Buy
8
Hold
0
Sell
0
Price Target (15 analysts)
$44.20
Range $40.00 – $50.00
+10.0%
Consensus $44.20 vs current $40.19